GlaxoSmithKline Bangladesh Limited announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was BDT 942.718 million compared to BDT 1,087.414 million a year ago. Operating income was BDT 148.392 million compared to BDT 172.956 million a year ago. Net income was BDT 137.292 million compared to BDT 134.808 million a year ago. Basic earnings per share from continuing operations was BDT 11.37 compared to BDT 12.76 a year ago. Basic earnings per share was BDT 11.4 compared to BDT 11.19 a year ago. For the half year, sales was BDT 2,097.086 million compared to BDT 2,316.982 million a year ago. Operating income was BDT 344.972 million compared to BDT 385.405 million a year ago. Net income was BDT 317.684 million compared to BDT 268.047 million a year ago. Basic earnings per share from continuing operations was BDT 26.82 compared to BDT 28.1 a year ago. Basic earnings per share was BDT 26.37 compared to BDT 22.25 a year ago.